Breaking News

BD Ramps Up Manufacturing Capacity

New manufacturing lines to provide U.S. govt. with access to hundreds of millions of needles and syringes to support U.S. vaccination agility and preparedness.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

BD (Becton, Dickinson and Company), a global medical technology company, has strengthened the U.S. government’s access to safety injection devices through increased manufacturing capacity and domestic supply. The new syringe and needle manufacturing lines, which were completed on an accelerated timeline, represent the public-private partnership between BD and Department of Health and Human Services’ (HHS) Assistant Secretary for Preparedness and Response (ASPR).   In July 2020, ASPR&...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters